GTG price jumps on Applera lawsuit news
Thursday, 16 September, 2004
The share price of Genetic Technologies (ASX: GTG) jumped 25 per cent today on heavy trading after the company announced that the judge in GTG's lawsuit against Applera had ruled largely in the company's favour during the Markman hearing, in which the court rules on the precise meanings of certain disputed technical terms within GTG's patent claims.
Out of 15 disputed terms, the court ruled in favour of GTG's definition in 13 cases, and for the remaining two terms, the court adopted a definition consistent with GTG's position.
At the time of writing, GTG's shares were trading at AUD$0.475, up from a previous close of $0.38.
AusBiotech partners with Tenmile
Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...
Australian CDC issues update in wake of Ebola outbreak
After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health...
Australia announces $7.2m diphtheria outbreak response package
To respond to the biggest diphtheria outbreak on record, support has been announced for the NT...
